Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Subtil

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Communications Biology|October 7, 2022
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, et al.
Endoscopy International Open|August 27, 2025
Histology of colonic submucosal lesions reveals a high proportion of benign lesions that do not require R0 en bloc endoscopic resectionPierre Lafeuille, Renato Medas, Benjamin Hamel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018Olivier Bylicki, Pascale Tomasini, Gervais Radj, et al.
JAMA Oncology|June 11, 2026
Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors: The TROPHAMET Phase 1/2 Nonrandomized Clinical TrialBenoit You, Jean-Pierre Lotz, Pierre Descargues, et al.
Endoscopy|March 3, 2020
Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resectionEmmanuel Forté, Bérénice Petit, Thomas Walter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
Biomarker Research|July 2, 2025
Diagnostic value of the wnt target and cancer-associated blood biomarker hPG80: ONCOPRO case-control prospective studyBenoit You, Sebastien Couraud, Philippe Ceruse, et al.
Endoscopy|July 27, 2023
Use of endoscopic submucosal dissection or full-thickness resection device to treat residual colorectal neoplasia after endoscopic resection: a multicenter historical cohort studyClara Yzet, Yann Le Baleur, Jérémie Albouys, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 2, 2019
Multicenter Evaluation of Clinical Efficacy and Safety of Per-oral Endoscopic Myotomy in ChildrenAdrien Choné, Pietro Familiari, Burkhard von Rahden, et al.
The American Journal of Gastroenterology|September 21, 2023
Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine TumorsLoïc Cheminel, Alexandru Lupu, Timothée Wallenhorst, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Communications Biology|October 7, 2022
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, et al.
Endoscopy International Open|August 27, 2025
Histology of colonic submucosal lesions reveals a high proportion of benign lesions that do not require R0 en bloc endoscopic resectionPierre Lafeuille, Renato Medas, Benjamin Hamel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018Olivier Bylicki, Pascale Tomasini, Gervais Radj, et al.
JAMA Oncology|June 11, 2026
Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors: The TROPHAMET Phase 1/2 Nonrandomized Clinical TrialBenoit You, Jean-Pierre Lotz, Pierre Descargues, et al.
Endoscopy|March 3, 2020
Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resectionEmmanuel Forté, Bérénice Petit, Thomas Walter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
Biomarker Research|July 2, 2025
Diagnostic value of the wnt target and cancer-associated blood biomarker hPG80: ONCOPRO case-control prospective studyBenoit You, Sebastien Couraud, Philippe Ceruse, et al.
Endoscopy|July 27, 2023
Use of endoscopic submucosal dissection or full-thickness resection device to treat residual colorectal neoplasia after endoscopic resection: a multicenter historical cohort studyClara Yzet, Yann Le Baleur, Jérémie Albouys, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 2, 2019
Multicenter Evaluation of Clinical Efficacy and Safety of Per-oral Endoscopic Myotomy in ChildrenAdrien Choné, Pietro Familiari, Burkhard von Rahden, et al.
The American Journal of Gastroenterology|September 21, 2023
Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine TumorsLoïc Cheminel, Alexandru Lupu, Timothée Wallenhorst, et al.
Pageof 17